September 14, 2020 | Business Wire
Cerveau Technologies, Inc. announces Formation of Scientific Advisory Board
Cerveau Technologies, Inc. today announced formation of its Scientific Advisory Board (SAB), comprised of top tier...
September 9, 2020 | SAB virtual conference
Cerveau Scientific Advisory Board Virtual Conference 2020
MK-6240 Users Group Meeting | Webinar #1 by Cerveau Technologies Inc 2020 Virtual Conference with world...
May 4, 2020 | Business Wire
Cerveau Technologies, Inc. Announces Collaboration with University College of London
BOSTON--(BUSINESS WIRE)--Cerveau Technologies Inc. today announced a research collaboration with University College London (UCL), a leading...
March 20, 2020 | Business Wire
Cerveau Technologies, Inc. Announces Collaboration with Alector, Inc.
BOSTON–(BUSINESS WIRE)–Cerveau Technologies Inc. today announced a licensing agreement with Alector, in which Cerveau will provide...
December 1, 2019 | Business Wire
Enigma Biomedical Group Announces Appointment of Michael Reitermann to Their Board of Directors
TORONTO–(BUSINESS WIRE)–Enigma Biomedical Group (EBG) today announced the appointment of Michael Reitermann to their Board of...
November 14, 2019 | Business Wire
Cerveau Technologies, Inc. Announces Initiation of Japanese Phase I Study
KNOXVILLE, Tennessee--(BUSINESS WIRE)--Cerveau Technologies, Inc. today announced that the first healthy volunteer was injected and scanned...
September 27, 2019 | Business Wire
Cerveau Technologies Inc. Signs Research Agreement with Takeda to Provide Novel Tau Imaging Agent
BOSTON–(BUSINESS WIRE)–Cerveau Technologies, Inc. today announced a research collaboration agreement with Takeda Pharmaceutical Company Limited (Takeda),...
May 19, 2019 | Business Wire
Cerveau Technologies, Inc. Announces a Partnership with LuMind IDSC Foundation to Study Accumulation of Neurofibrillary Tau in Down Syndrome
BOSTON--(BUSINESS WIRE)--Cerveau Technologies, Inc. today announced a research collaboration with the LuMind IDSC Foundation (LuMind IDSC)...
March 22, 2019 | Business Wire
Cerveau Technologies Inc. Signs Research Agreement with Eisai Inc., for Novel Tau Imaging Agent
BOSTON--(BUSINESS WIRE)--Cerveau Technologies, Inc. today announced a research collaboration agreement with Eisai Inc., which will enable...